akhatri

MHRA Class 2 Medicines Recall: Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes Drug alert number: EL(26)A/01 Date issued: 20 January 2026 Mercury Pharmaceuticals Ltd is recalling remaining stock of paliperidone pre-filled syringes as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies cited during a recent inspection at the finished product [...]

The post MHRA Class 2 Medicines Recall: Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes appeared first on Community Pharmacy England.

Pharmacy teams should be aware that all strengths of Subutex® and Suboxone® tablets have been discontinued. The manufacturer, Indivior, is no longer supplying these products in the UK therefore, they are no longer available for community pharmacies to order. Please note that if a prescriber has issued a branded prescription for any strength of Subutex®, [...]

The post Discontinuation of Subutex® and Suboxone® tablets appeared first on Community Pharmacy England.

The MHRA has reviewed the warnings regarding addiction, dependence, withdrawal, and tolerance for gabapentin, pregabalin, benzodiazepines, and z-drugs. The findings (detailed in the Public Assessment Report) were that it was necessary to strengthen these warnings in the product information and on packaging to better inform healthcare professionals and patients of these known risks. Advice for [...]

The post MHRA Drug Safety Update: Improving Information Supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 January 2026. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Elafibranor 80mg tablets Iqirvo® 80mg tablets (Ipsen Ltd) 30 tablet Complete pack Desmopressin 60microgram [...]

The post 7 products re-classified as special containers from January 2026 appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 January 2026. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Elafibranor 80mg tablets Iqirvo® 80mg tablets (Ipsen Ltd) 30 tablet Complete pack Desmopressin 60microgram [...]

The post 7 products re-classified as special containers from January 2026 appeared first on Community Pharmacy England.